OIM
WGS icon

Oracle Investment Management’s GeneDx Holdings WGS Stock Holding History

Oracle Investment Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100,000
Closed -$9.23M – 22
2025
Q2 		$9.23M Buy
+100,000
New +$7.85M 6.33% 3

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Oracle Investment Management's WGS Position: Q4 2025 in Review

Oracle Investment Management reduced its GeneDx Holdings (WGS) stake by 0.6% in Q4 2025, selling an estimated $727K and leaving 884,654 shares worth $115M. The position accounts for 68.51% of the portfolio, ranked #1.

Oracle Investment Management first reported a position in WGS in Q1 2022 and has held it in 16 quarters since. 286 funds tracked by Wall St. Rank hold WGS as of Q4 2025.

  • Oracle Investment Management held 884,654 shares of GeneDx Holdings worth $115M as of Q4 2025.
  • Oracle Investment Management sold 5,300 GeneDx Holdings shares in Q4 2025, an estimated $727K.
  • GeneDx Holdings made up 68.51% of Oracle Investment Management's portfolio in Q4 2025, its #1 holding.
  • Oracle Investment Management first reported a position in GeneDx Holdings in Q1 2022 and has held it in 16 quarters since.
  • 286 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2025.

Based on Oracle Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.